Portage Biotech (PRTG) Competitors $7.02 +1.15 (+19.59%) Closing price 08/5/2025 03:59 PM EasternExtended Trading$6.90 -0.11 (-1.64%) As of 04:16 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PRTG vs. FBLG, ASBP, LGVN, AYTU, LSTA, NAII, DARE, RVPH, CVKD, and ELEVShould you be buying Portage Biotech stock or one of its competitors? The main competitors of Portage Biotech include FibroBiologics (FBLG), Aspire Biopharma (ASBP), Longeveron (LGVN), Aytu BioPharma (AYTU), Lisata Therapeutics (LSTA), Natural Alternatives International (NAII), Dare Bioscience (DARE), Reviva Pharmaceuticals (RVPH), Cadrenal Therapeutics (CVKD), and Elevation Oncology (ELEV). These companies are all part of the "pharmaceutical products" industry. Portage Biotech vs. Its Competitors FibroBiologics Aspire Biopharma Longeveron Aytu BioPharma Lisata Therapeutics Natural Alternatives International Dare Bioscience Reviva Pharmaceuticals Cadrenal Therapeutics Elevation Oncology Portage Biotech (NASDAQ:PRTG) and FibroBiologics (NASDAQ:FBLG) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, earnings, valuation, profitability, dividends, media sentiment and institutional ownership. Do analysts prefer PRTG or FBLG? FibroBiologics has a consensus target price of $13.00, indicating a potential upside of 2,241.08%. Given FibroBiologics' stronger consensus rating and higher possible upside, analysts clearly believe FibroBiologics is more favorable than Portage Biotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Portage Biotech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00FibroBiologics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20 Which has more risk & volatility, PRTG or FBLG? Portage Biotech has a beta of 0.24, indicating that its share price is 76% less volatile than the S&P 500. Comparatively, FibroBiologics has a beta of -0.74, indicating that its share price is 174% less volatile than the S&P 500. Which has higher valuation and earnings, PRTG or FBLG? FibroBiologics is trading at a lower price-to-earnings ratio than Portage Biotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPortage BiotechN/AN/A-$6.77M-$41.65-0.17FibroBiologicsN/AN/A-$11.16M-$0.36-1.54 Is PRTG or FBLG more profitable? Portage Biotech's return on equity of 0.00% beat FibroBiologics' return on equity.Company Net Margins Return on Equity Return on Assets Portage BiotechN/A N/A N/A FibroBiologics N/A -710.25%-118.02% Do institutionals and insiders believe in PRTG or FBLG? 13.4% of Portage Biotech shares are owned by institutional investors. 20.8% of FibroBiologics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the media favor PRTG or FBLG? In the previous week, FibroBiologics had 6 more articles in the media than Portage Biotech. MarketBeat recorded 6 mentions for FibroBiologics and 0 mentions for Portage Biotech. Portage Biotech's average media sentiment score of 0.00 beat FibroBiologics' score of -0.33 indicating that Portage Biotech is being referred to more favorably in the media. Company Overall Sentiment Portage Biotech Neutral FibroBiologics Neutral SummaryPortage Biotech and FibroBiologics tied by winning 7 of the 14 factors compared between the two stocks. Get Portage Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for PRTG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PRTG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRTG vs. The Competition Export to ExcelMetricPortage BiotechMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.16M$3.07B$5.59B$9.53BDividend YieldN/A2.41%4.73%4.14%P/E Ratio-0.1717.5328.9123.88Price / SalesN/A313.17448.7998.82Price / CashN/A42.6035.6858.35Price / Book-8.897.828.165.60Net Income-$6.77M-$54.52M$3.25B$265.26M7 Day Performance13.23%2.86%1.15%-0.14%1 Month Performance19.80%17.29%8.25%6.08%1 Year Performance121.93%13.27%29.18%24.22% Portage Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PRTGPortage BiotechN/A$7.02+19.6%N/A+149.5%$6.16MN/A-0.176High Trading VolumeFBLGFibroBiologics3.2315 of 5 stars$0.60-7.9%$13.00+2,052.3%-85.3%$24.01MN/A-2.8810Earnings ReportAnalyst ForecastASBPAspire BiopharmaN/A$0.48-1.2%N/AN/A$23.55MN/A0.00N/ALGVNLongeveron2.3898 of 5 stars$1.56-4.8%$8.67+455.2%-41.5%$23.52M$2.39M-0.2520News CoverageUpcoming EarningsShort Interest ↑Gap DownAYTUAytu BioPharma3.1962 of 5 stars$2.55-3.2%$10.00+292.9%+1.6%$22.85M$81M-3.53160LSTALisata Therapeutics2.3261 of 5 stars$2.64+0.4%$23.50+790.2%-0.3%$22.76M$1M-1.1530Upcoming EarningsNAIINatural Alternatives InternationalN/A$3.65+1.4%N/A-32.3%$22.56M$113.80M-2.63290Positive NewsDAREDare Bioscience1.6186 of 5 stars$2.48-2.7%$12.00+383.9%-25.2%$22.44M$10K-14.6230Upcoming EarningsRVPHReviva Pharmaceuticals2.8697 of 5 stars$0.46-5.7%$9.00+1,848.1%-51.7%$22.27MN/A-0.595Upcoming EarningsShort Interest ↑CVKDCadrenal Therapeutics2.1572 of 5 stars$11.12-4.0%$32.00+187.9%N/A$21.90MN/A-1.204News CoverageGap UpELEVElevation Oncology2.142 of 5 stars$0.37flat$3.39+827.6%N/A$21.62MN/A-0.4540 Related Companies and Tools Related Companies FibroBiologics Alternatives Aspire Biopharma Alternatives Longeveron Alternatives Aytu BioPharma Alternatives Lisata Therapeutics Alternatives Natural Alternatives International Alternatives Dare Bioscience Alternatives Reviva Pharmaceuticals Alternatives Cadrenal Therapeutics Alternatives Elevation Oncology Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PRTG) was last updated on 8/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | SponsoredStrange twist to Bitcoin’s rallyThe #1 crypto to buy today Better than Bitcoin? (top crypto for less than $1) Over the past 15 years, B...Stansberry Research | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Portage Biotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Portage Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
